LungLife AI ^Corporations

LungLife AI is a molecular diagnostics company that focuses on the early detection and treatment of lung cancer. Using machine learning and artificial intelligence, the company aims to enable life-saving early diagnosis of lung cancer. Their diagnostic technology, combined with image analysis and machine learning, improves workflow efficiencies and performance. The company is developing tests that cover all stages of lung cancer, from aiding in diagnosis for early-stage patients to treatment stratification and monitoring for late-stage patients. Founded in 2008 and headquartered in Thousand Oaks, California, LungLife AI works with scientific and clinical partners to achieve their goal of being a driving force in the early detection of lung cancer.